Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Wins $24M from US Government to Study Toxicogenomics

NEW YORK, Oct. 1 - Paradigm Genetics yesterday said it has been awarded $23.8 million from the National Institute of Environmental Health to perform gene-expression studies related to toxicology.


For the next five years, Paradigm researchers will use a gene-expression platform based on technology developed at Agilent Technologies to discern what happens to an organism when an undisclosed variety of toxicants, drugs, and pesticides have been introduced.


Paradigm added that this research will serve as a link between the company's ag-biotech and human-health research.


Click here for more information.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.